McKesson Corporation (0JZU.L)
USD 705.49
(-0.86%)
USD 705.49
(-0.86%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 308.95 Billion USD | 11.65% |
| 2022 | 276.71 Billion USD | 4.83% |
| 2021 | 263.96 Billion USD | 10.8% |
| 2020 | 238.22 Billion USD | 3.11% |
| 2019 | 231.05 Billion USD | 7.81% |
| 2018 | 214.31 Billion USD | 2.86% |
| 2017 | 208.35 Billion USD | 4.95% |
| 2016 | 198.53 Billion USD | 4.01% |
| 2015 | 190.88 Billion USD | 6.61% |
| 2014 | 179.04 Billion USD | 30.32% |
| 2013 | 137.39 Billion USD | 12.44% |
| 2012 | 122.19 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 79.28 Billion USD | 3.83% |
| 2023 Q1 | 74.48 Billion USD | 8.09% |
| 2023 Q2 | 77.21 Billion USD | 3.67% |
| 2023 FY | 308.95 Billion USD | 11.65% |
| 2023 Q3 | 80.89 Billion USD | 4.77% |
| 2023 Q4 | 76.35 Billion USD | -5.62% |
| 2022 Q2 | 70.15 Billion USD | 4.47% |
| 2022 Q1 | 67.15 Billion USD | 1.59% |
| 2022 Q4 | 68.91 Billion USD | -2.24% |
| 2022 FY | 276.71 Billion USD | 4.83% |
| 2022 Q3 | 70.49 Billion USD | 0.47% |
| 2021 FY | 263.96 Billion USD | 10.8% |
| 2021 Q1 | 62.67 Billion USD | 5.97% |
| 2021 Q2 | 66.57 Billion USD | 6.23% |
| 2021 Q4 | 66.1 Billion USD | -3.66% |
| 2021 Q3 | 68.61 Billion USD | 3.06% |
| 2020 Q4 | 59.14 Billion USD | -5.52% |
| 2020 FY | 238.22 Billion USD | 3.11% |
| 2020 Q1 | 55.67 Billion USD | -4.88% |
| 2020 Q2 | 60.8 Billion USD | 9.21% |
| 2020 Q3 | 62.59 Billion USD | 2.95% |
| 2019 Q3 | 59.17 Billion USD | 2.7% |
| 2019 Q4 | 58.53 Billion USD | -1.08% |
| 2019 Q1 | 55.72 Billion USD | 6.29% |
| 2019 Q2 | 57.61 Billion USD | 3.39% |
| 2019 FY | 231.05 Billion USD | 7.81% |
| 2018 FY | 214.31 Billion USD | 2.86% |
| 2018 Q4 | 52.42 Billion USD | -6.72% |
| 2018 Q3 | 56.2 Billion USD | 5.9% |
| 2018 Q2 | 53.07 Billion USD | 0.89% |
| 2018 Q1 | 52.6 Billion USD | 1.9% |
| 2017 Q1 | 51.05 Billion USD | 4.8% |
| 2017 Q2 | 52.06 Billion USD | 1.98% |
| 2017 Q3 | 53.61 Billion USD | 2.99% |
| 2017 Q4 | 51.62 Billion USD | -3.71% |
| 2017 FY | 208.35 Billion USD | 4.95% |
| 2016 FY | 198.53 Billion USD | 4.01% |
| 2016 Q4 | 48.71 Billion USD | -2.83% |
| 2016 Q3 | 50.13 Billion USD | 0.35% |
| 2016 Q2 | 49.95 Billion USD | 0.45% |
| 2016 Q1 | 49.73 Billion USD | 6.54% |
| 2015 FY | 190.88 Billion USD | 6.61% |
| 2015 Q4 | 46.67 Billion USD | -2.55% |
| 2015 Q3 | 47.89 Billion USD | -1.77% |
| 2015 Q1 | 47.54 Billion USD | 5.83% |
| 2015 Q2 | 48.76 Billion USD | 2.56% |
| 2014 Q4 | 44.92 Billion USD | -3.35% |
| 2014 FY | 179.04 Billion USD | 30.32% |
| 2014 Q1 | 43.47 Billion USD | 14.92% |
| 2014 Q2 | 44.16 Billion USD | 1.57% |
| 2014 Q3 | 46.48 Billion USD | 5.26% |
| 2013 FY | 137.39 Billion USD | 12.44% |
| 2013 Q1 | 32.23 Billion USD | 5.65% |
| 2013 Q3 | 34.33 Billion USD | 4.1% |
| 2013 Q4 | 37.83 Billion USD | 10.18% |
| 2013 Q2 | 32.98 Billion USD | 2.31% |
| 2012 Q3 | 31.09 Billion USD | 0.0% |
| 2012 Q4 | 30.51 Billion USD | -1.87% |
| 2012 FY | 122.19 Billion USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -86611.161% |
| Accuray Incorporated | 446.55 Million USD | -69086.05% |
| Align Technology, Inc. | 3.86 Billion USD | -7899.228% |
| Elevance Health Inc. | 171.34 Billion USD | -80.315% |
| AxoGen, Inc. | 159.01 Million USD | -194194.141% |
| Boston Scientific Corporation | 14.24 Billion USD | -2069.6% |
| CVS Health Corporation | 357.77 Billion USD | 13.647% |
| Cardinal Health, Inc. | 226.82 Billion USD | -36.206% |
| Centene Corporation | 141.26 Billion USD | -118.702% |
| DaVita Inc. | 12.14 Billion USD | -2444.87% |
| HCA Healthcare, Inc. | 64.96 Billion USD | -375.543% |
| Hologic, Inc. | 4.03 Billion USD | -7565.707% |
| Humana Inc. | 106.37 Billion USD | -190.438% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -8339.087% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | -2440.381% |
| Masimo Corporation | 2.04 Billion USD | -14984.761% |
| Patterson Companies, Inc. | 6.56 Billion USD | -4603.688% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | -3239.289% |
| ResMed Inc. | 4.68 Billion USD | -6494.054% |
| Henry Schein, Inc. | 12.33 Billion USD | -2403.858% |
| Teladoc Health, Inc. | 2.6 Billion USD | -11771.704% |
| Universal Health Services, Inc. | 14.28 Billion USD | -2063.223% |
| Veeva Systems Inc. | 2.36 Billion USD | -12970.801% |
| Baxter International Inc. | 14.81 Billion USD | -1985.675% |
| Becton, Dickinson and Company | 19.37 Billion USD | -1494.833% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | -4236.702% |
| Danaher Corporation | 23.89 Billion USD | -1193.223% |
| Stryker Corporation | 20.49 Billion USD | -1407.225% |
| Medtronic plc | 32.36 Billion USD | -854.613% |